Publications (34) Publications in which a researcher has participated


  1. A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices

    Hepatology, Vol. 70, Núm. 4, pp. 1377-1391

  2. A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy

    Journal of Neurochemistry, Vol. 151, Núm. 1, pp. 103-115

  3. Abstract C088: Chemical phosphoproteomics systematically identifies circuitries of kinase networks in cancer cells and predicts their response to kinase inhibitors

    Molecular Cancer Therapeutics, Vol. 18, Núm. 12_Supplement, pp. C088-C088

  4. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization

    Neuropharmacology, Vol. 146, pp. 19-27

  5. Biopiracy versus One-World Medicine–From colonial relicts to global collaborative concepts

    Phytomedicine, Vol. 53, pp. 319-331

  6. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease

    Acta Physiologica, Vol. 226, Núm. 2

  7. Central role of cell cycle regulation in the antitumoral action of ocoxin

    Nutrients, Vol. 11, Núm. 5

  8. Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in mice

    Cell Death and Disease, Vol. 10, Núm. 11

  9. Connexins in cancer: bridging the gap to the clinic

    Oncogene, Vol. 38, Núm. 23, pp. 4429-4451

  10. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

    British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104

  11. Does APC/CCDH1 control the human brain size?: An Editorial Highlight for ‘A novel human Cdh1 mutation impairs anaphase-promoting complex/cyclosome (APC/C) activity resulting in microcephaly, psychomotor retardation, and epilepsy’ on page 103

    Journal of Neurochemistry, Vol. 151, Núm. 1, pp. 8-10

  12. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800

  13. Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

    Nature Communications, Vol. 10, Núm. 1

  14. Exploring target genes involved in the effect of quercetin on the response to oxidative stress in caenorhabditis elegans

    Antioxidants, Vol. 8, Núm. 12

  15. Farmacogenómica: la medicina personalizada

    Revista del laboratorio clínico, Vol. 12, Núm. 3, pp. 147-154

  16. Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP

    Current Pharmaceutical Design, Vol. 25, Núm. 4, pp. 376-380

  17. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells

    Gastroenterology, Vol. 157, Núm. 5, pp. 1398-1412.e9

  18. Male reproductive dysfunction in Solea senegalensis: New insights into an unsolved question

    Reproduction, Fertility and Development, Vol. 31, Núm. 6, pp. 1104-1115

  19. Neuronal p38α mediates age-associated neural stem cell exhaustion and cognitive decline

    Aging Cell, Vol. 18, Núm. 6

  20. Novel Pure αvβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations

    ACS Pharmacology and Translational Science, Vol. 2, Núm. 6, pp. 387-401